Venus Medtech Hangzhou Inc

Common Name
Venus Medtech Hangzhou
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Devices
Employees
691
Ticker
2500
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Venus Medtech (Hangzhou) Inc. is a leading developer and manufacturer of transcatheter heart valve systems and related medical devices. The company's primary function is to innovate and produce advanc...

Venus Medtech Hangzhou's GHG Emissions Data Preview

In 2023, Venus Medtech Hangzhou completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Venus Medtech Hangzhou has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Venus Medtech Hangzhou's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Venus Medtech Hangzhou amounted to 4,109.44 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Venus Medtech Hangzhou decreased by 7.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Venus Medtech Hangzhou's Scope 1 Emissions Over Time

20202021202220230255075100tCO2e-55%+115%+27%
  • Total Scope 1
  • Year-over-Year Change

What are Venus Medtech Hangzhou's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Venus Medtech Hangzhou were 88.82 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has Venus Medtech Hangzhou reduced its Scope 1 emissions over time?

Since 2020, Venus Medtech Hangzhou's Scope 1 emissions have increased by 22.73%, reflecting a rising long-term trend in Scope 1 emissions over time.

Compared to the previous year (2022), Venus Medtech Hangzhou's Scope 1 emissions increased by 26.51%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.

What are Venus Medtech Hangzhou's Scope 2 emissions?

In 2023, Venus Medtech Hangzhou reported Scope 2 greenhouse gas (GHG) emissions of 4,020.62 tCOâ‚‚e without specifying the calculation method.

Has Venus Medtech Hangzhou reduced its Scope 2 emissions over time?

Since 2020, Venus Medtech Hangzhou's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 75.34%, reflecting a rising long-term trend in Scope 2 emissions over time.

Compared to the previous year (2022), Venus Medtech Hangzhou's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Venus Medtech Hangzhou 's emissions have plateaued with no significant change in its energy consumption footprint.

What methodology does Venus Medtech Hangzhou use for Scope 2 reporting?

In 2023, Venus Medtech Hangzhou reported its Scope 2 emissions using an unspecified methodology.

Venus Medtech Hangzhou's Scope 2 Emissions Over Time

202020212022202301.5 k3 k4.5 k6 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)